NO307645B1 - Anvendelse av probenecid i kombinasjon med en eksitatorisk aminosyre-antagonist for fremstilling av et farmasøytisk preparat - Google Patents
Anvendelse av probenecid i kombinasjon med en eksitatorisk aminosyre-antagonist for fremstilling av et farmasøytisk preparatInfo
- Publication number
- NO307645B1 NO307645B1 NO940809A NO940809A NO307645B1 NO 307645 B1 NO307645 B1 NO 307645B1 NO 940809 A NO940809 A NO 940809A NO 940809 A NO940809 A NO 940809A NO 307645 B1 NO307645 B1 NO 307645B1
- Authority
- NO
- Norway
- Prior art keywords
- amino acid
- probenecid
- excitatory amino
- combination
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US75640191A | 1991-09-09 | 1991-09-09 | |
PCT/US1992/007540 WO1993004688A1 (en) | 1991-09-09 | 1992-09-02 | Pharmaceutical preparation containing an uricosuric and an excitatory amino acid antagonist |
Publications (3)
Publication Number | Publication Date |
---|---|
NO940809L NO940809L (no) | 1994-03-08 |
NO940809D0 NO940809D0 (no) | 1994-03-08 |
NO307645B1 true NO307645B1 (no) | 2000-05-08 |
Family
ID=25043303
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO940809A NO307645B1 (no) | 1991-09-09 | 1994-03-08 | Anvendelse av probenecid i kombinasjon med en eksitatorisk aminosyre-antagonist for fremstilling av et farmasøytisk preparat |
Country Status (16)
Country | Link |
---|---|
US (4) | US5407935A (xx) |
EP (1) | EP0603301B1 (xx) |
JP (1) | JP3218038B2 (xx) |
AT (1) | ATE162075T1 (xx) |
AU (1) | AU660717B2 (xx) |
CA (1) | CA2115442C (xx) |
DE (1) | DE69224069T2 (xx) |
DK (1) | DK0603301T3 (xx) |
ES (1) | ES2113957T3 (xx) |
GR (1) | GR3026369T3 (xx) |
MX (1) | MX9205127A (xx) |
NO (1) | NO307645B1 (xx) |
NZ (1) | NZ244243A (xx) |
PT (1) | PT100850B (xx) |
WO (1) | WO1993004688A1 (xx) |
ZA (1) | ZA926837B (xx) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU660717B2 (en) * | 1991-09-09 | 1995-07-06 | Warner-Lambert Company | Pharmaceutical preparation containing an uricosuric and an excitatory amino acid antagonist |
US5318985A (en) * | 1991-12-20 | 1994-06-07 | Merrell Dow Pharmaceuticals Inc. | Potentiation of NMDA antagonists |
US5854217A (en) | 1992-09-28 | 1998-12-29 | Bearsden Bio, Inc. | Allosteric modulators of the NMDA receptor and their use in the treatment of CNS disorders and enhancement of CNS function |
JPH07505908A (ja) * | 1992-09-28 | 1995-06-29 | マックセチーニ、マリア ルイザ | Nmda受容体のアロステリックモジュレーター |
AU735389B2 (en) | 1996-07-22 | 2001-07-05 | Cognetix, Inc. | Use of conantokins |
US6277825B1 (en) | 1996-07-22 | 2001-08-21 | University Of Utah Research Foundation | Use of conantokins for treating pain |
CA2261568A1 (en) | 1996-07-22 | 1998-01-29 | University Of Utah Research Foundation | Conantokins |
IL125950A0 (en) * | 1997-09-05 | 1999-04-11 | Pfizer Prod Inc | Methods of administering ampa receptor antagonists to treat dyskinesias associated with dopamine agonist therapy |
NZ508414A (en) * | 1998-05-26 | 2003-12-19 | Carlen Peter Louis | Compositions and methods for alleviating impaired mental function, memory loss and reducing recovery time in anaesthetized mammals |
US6399574B1 (en) | 2000-03-22 | 2002-06-04 | University Of Utah Research Foundation | Use of conantokins |
US7799794B2 (en) | 2000-06-28 | 2010-09-21 | Merck Sharp & Dohme Corp. | Treatment for cardiovascular disease |
US7276514B2 (en) * | 2002-05-15 | 2007-10-02 | Charitable Leadership Foundation - Medical Technology Acceleration Program | Pyrroloquinoline quinone drugs for treatment of cardiac injury and methods of use thereof |
US20080051428A1 (en) * | 2002-05-15 | 2008-02-28 | Davis Paul J | Pyrroloquinoline quinone drugs and methods of use thereof |
US20040152694A1 (en) * | 2003-02-04 | 2004-08-05 | Istvan Kurucz | Methods and compositions for treating inflammatory disorders of the airways |
EP1735057B1 (en) * | 2004-03-22 | 2015-02-25 | Apkarian Technologies LLC | Method and compositions for treatment of chronic neuropathic pain |
US8461223B2 (en) * | 2005-04-07 | 2013-06-11 | Aspen Aerogels, Inc. | Microporous polycyclopentadiene-based aerogels |
ITFI20050083A1 (it) * | 2005-04-29 | 2006-10-30 | Univ Firenze | Uso dell'acido chinurenico per la prevenzione e il trattamento dello shock |
US8841333B2 (en) | 2005-05-09 | 2014-09-23 | Takeda Pharmaceuticals U.S.A., Inc. | Methods for treating nephrolithiasis |
WO2007140293A2 (en) | 2006-05-25 | 2007-12-06 | Aspen Aerogels, Inc. | Aerogel compositions with enhanced performance |
EP2338492A1 (en) | 2009-12-24 | 2011-06-29 | Universidad del Pais Vasco | Methods and compositions for the treatment of alzheimer |
JP5978216B2 (ja) | 2010-09-10 | 2016-08-24 | タケダ ファーマシューティカルズ ユー.エス.エー. インコーポレイティド | テオフィリンとフェブキソスタットの併用療法のための方法 |
US10806711B2 (en) | 2011-08-12 | 2020-10-20 | University Of Cincinnati | Method of treating acute decompensated heart failure with probenecid |
AU2014244053B2 (en) | 2013-03-13 | 2018-08-30 | University Of Cincinnati | Treatment of a diastolic cardiac dysfunction with a TRPV2 receptor agonist |
US20170143681A1 (en) | 2015-11-02 | 2017-05-25 | Apkarian Technologies Llc | Methods and compositions for treating pain |
EP3427729A1 (en) * | 2017-07-13 | 2019-01-16 | Paris Sciences et Lettres - Quartier Latin | Probenecid for use in treating epileptic diseases, disorders or conditions |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4812458A (en) * | 1986-09-16 | 1989-03-14 | A/S Ferrosan | 6,7-disubstituted-2,3-dihydroxyquinoxaline compounds, pharmaceutical compositions thereof, and their use as neuroleptics |
DK146787A (da) * | 1987-03-23 | 1988-09-24 | Ferrosan | Heterocykliske forbindelser, deres fremstilling og anvendelse |
EP0501378B1 (en) * | 1991-02-28 | 1995-01-11 | Merrell Dow Pharmaceuticals Inc. | NMDA Antagonists |
AU660717B2 (en) * | 1991-09-09 | 1995-07-06 | Warner-Lambert Company | Pharmaceutical preparation containing an uricosuric and an excitatory amino acid antagonist |
-
1992
- 1992-09-02 AU AU25943/92A patent/AU660717B2/en not_active Ceased
- 1992-09-02 DE DE69224069T patent/DE69224069T2/de not_active Expired - Fee Related
- 1992-09-02 WO PCT/US1992/007540 patent/WO1993004688A1/en active IP Right Grant
- 1992-09-02 CA CA002115442A patent/CA2115442C/en not_active Expired - Fee Related
- 1992-09-02 ES ES92919882T patent/ES2113957T3/es not_active Expired - Lifetime
- 1992-09-02 AT AT92919882T patent/ATE162075T1/de not_active IP Right Cessation
- 1992-09-02 EP EP92919882A patent/EP0603301B1/en not_active Expired - Lifetime
- 1992-09-02 DK DK92919882T patent/DK0603301T3/da active
- 1992-09-02 JP JP50544593A patent/JP3218038B2/ja not_active Expired - Fee Related
- 1992-09-07 NZ NZ244243A patent/NZ244243A/en unknown
- 1992-09-08 MX MX9205127A patent/MX9205127A/es not_active IP Right Cessation
- 1992-09-08 PT PT100850A patent/PT100850B/pt not_active IP Right Cessation
- 1992-09-08 ZA ZA926837A patent/ZA926837B/xx unknown
-
1993
- 1993-04-19 US US08/049,228 patent/US5407935A/en not_active Expired - Fee Related
-
1994
- 1994-03-08 NO NO940809A patent/NO307645B1/no not_active IP Right Cessation
-
1995
- 1995-10-05 US US08/539,398 patent/US5627168A/en not_active Expired - Fee Related
-
1996
- 1996-12-31 US US08/775,637 patent/US5767119A/en not_active Expired - Fee Related
-
1998
- 1998-03-13 GR GR980400554T patent/GR3026369T3/el unknown
- 1998-03-27 US US09/049,495 patent/US5942513A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO1993004688A1 (en) | 1993-03-18 |
EP0603301A1 (en) | 1994-06-29 |
JP3218038B2 (ja) | 2001-10-15 |
US5407935A (en) | 1995-04-18 |
EP0603301B1 (en) | 1998-01-14 |
PT100850A (pt) | 1993-10-29 |
US5942513A (en) | 1999-08-24 |
DK0603301T3 (da) | 1998-09-14 |
MX9205127A (es) | 1993-07-01 |
NZ244243A (en) | 1995-07-26 |
AU660717B2 (en) | 1995-07-06 |
JPH06510544A (ja) | 1994-11-24 |
US5627168A (en) | 1997-05-06 |
AU2594392A (en) | 1993-04-05 |
ATE162075T1 (de) | 1998-01-15 |
CA2115442C (en) | 2003-09-23 |
ES2113957T3 (es) | 1998-05-16 |
PT100850B (pt) | 1999-07-30 |
US5767119A (en) | 1998-06-16 |
DE69224069D1 (de) | 1998-02-19 |
GR3026369T3 (en) | 1998-06-30 |
NO940809L (no) | 1994-03-08 |
ZA926837B (en) | 1994-03-08 |
DE69224069T2 (de) | 1998-07-02 |
CA2115442A1 (en) | 1993-03-18 |
NO940809D0 (no) | 1994-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO307645B1 (no) | Anvendelse av probenecid i kombinasjon med en eksitatorisk aminosyre-antagonist for fremstilling av et farmasøytisk preparat | |
ATE211384T1 (de) | Verwendung von adenosinantagonisten zur vorbeugung und behandlung von pankreatitis und ulcera | |
DE69725293D1 (de) | N-(2 oxoacetyl oder sulphonyl)-pyrrolidine/piperidine-2-carbonsäurederivate mit verbesserter multi-drug resistenz aktivität | |
ATE184792T1 (de) | 2-bromomelatonin zur behandlung von schlafstörungen | |
ATE245977T1 (de) | Therapeutische substituierte guanidine | |
ATE119520T1 (de) | Derivate von hydroxaminsäure und von n- hydroxyharnstoff sowie ihre verwendung. | |
FI941826A (fi) | Menetelmät ja koostumukset elimen hypofunktion ennaltaehkäisemiseksi ja/tai terapeuttiseksi hoitamiseksi | |
PT807633E (pt) | Novas pirimidin-4-onas substituidas em 2,3, e fundidas com heteroarilo em (5,6) | |
UA41355C2 (uk) | Засіб для лікування нейро-сніду | |
PT627221E (pt) | Substancias antagonistas p para o tratamento de emese | |
DK599789A (da) | 3,5-di-tertiaer-butyl-4-hydroxyphenyl-1,3,4-thiadazoler og -oxadiazoler samt 3,5-di-tertiaer-butyl-4-hydroxyphenyl-1,2,4-thiadazoler, -oxadiazoler og -triazoler som anti-inflammatoriske midler | |
PT100947A (pt) | Pirrolidinonas heterociclicas, composicoes farmaceuticas contendo estes compostos e seu uso no tratamento de doencas alergicas e inflamatorias e para a inibicao da producao de factor de necrose tumoral | |
ES2106531T3 (es) | Compuestos de dibenzoxazepina substituidos en 2, 3, 4, 5, 6, 7, 8, 9 y/o 10, composiciones farmaceuticas y metodos de uso. | |
ATE381327T1 (de) | Cethylmyristat und cetylpalmitat zurbehandlung von ekzemen und/oder psoriasis | |
DE69820053D1 (de) | Stör-notokord zur verminderung der symptome / behandlung von arthritis | |
EA200000242A1 (ru) | Применение фанхинона для лечения болезни альцгеймера | |
DE59106201D1 (de) | Dermatologische Zusammensetzungen mit einem Gehalt an cis-Urocaninsäure. | |
BR9812531A (pt) | Combinação de componentes, preparação farmacêutica, produção desta, e, uso da combinação ou da preparação farmacêutica | |
ES2038216T3 (es) | Procedimiento para la preparacion de 5-(3-alquil-5-t-butil-4-hidroxi-fenil)-2-amino-6h-1,3,4-tiadazinas y su empleo. | |
YU39396A (sh) | Upotreba izolovanog prirodnog proteina gojaznosti za pripremu leka i njegova farmaceutska formulacija | |
DE69103773D1 (de) | Derivate von hydroxaminsäure die lipoxygenase hemmen. | |
DE69630876D1 (de) | Verwendung von penciclovir zur behandlung von menschlichem herpes virus-8 | |
DE69429447D1 (de) | Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 7 infektionen | |
DE69429538D1 (de) | Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 6 infektionen | |
DE69201975D1 (de) | Pyrimido-benzothiazinderivate zur Behandlung von Entzündung, Allergie and kardiovaskulären Erkrankung. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |